Matthew Morgan
Matthew Morgan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- David Hepburn
Hull York Medical School Hull University Teaching Hospitals NHS Trust Hull United Kingdom
1 shared publication - Joanne Reeve
University of Hull
1 shared publication - Paul E. S. Crampton
Health Professions Education Unit, Hull York Medical School University of York York UK
1 shared publication - Richard Bodington
Health Professions Education Unit, Hull‐York Medical School University of York York UK
1 shared publication
Latest Publications
- Open Access
- 20 January 2026
- Published by Ubiquity Press, Ltd. in Perspectives on Medical Education
- Vol. 15 (1) , 647-662
Understanding undergraduate medicines optimisation education and its importance; a realist evaluation
Introduction Problematic polypharmacy (PP) is associated with risks and burdens for patients, and waste for healthcare systems. To overcome this challenge, clinicians must be able to tailor clinical decisions to patients’ individual circumstances by integrating biomedical with biographical accounts of illness. This skillset has not been well defined or taught. Medicines optimisation (MO) is a key clinical activity in tackling PP and can exemplify the practical wisdom required for this integration. How and why MO education works is poorly understood. Our previous work, a realist review of published interventions, addressed this gap by explaining how undergraduate MO education could work but was limited by the thin descriptions available. Here, we develop those findings by using primary data from interviews of expert educators to develop and refine our explanatory model. Methods This realist evaluation develops the programme theory from our review using primary data from individual realist interviews of MO experts. Realist configurational analysis was used. The study is conducted and reported in-keeping with RAMESES II standards. Results Sixteen experts in MO were interviewed; data were used to refine or refute our previous theorising. Analysis showed MO education which seeks to integrate interpretive practice into clinical decision-making must be valued by learners and be sufficiently aligned with educational and workplace culture to garner the engagement necessary to undertake this learning process. Learners must feel they have permission to practice interpretive medicine when healthcare structures are organised to the contrary. A perception of critical mass within a community of practice may facilitate the required security in decision-making for ongoing practice. Discussion We describe how and why undergraduate MO educational programmes can work to produce important outcomes in tackling the challenge of PP. We highlight how MO educational programmes may also act as practical gateways to routine interpretive practice in broader clinical areas.
- 20 January 2026
- Published by Ubiquity Press, Ltd. in Perspectives on Medical Education
- Vol. 15 (1) , 647-662
Open AccessUnderstanding undergraduate medicines optimisation education and its importance; a realist evaluation
Introduction Problematic polypharmacy (PP) is associated with risks and burdens for patients, and waste for healthcare systems. To overcome this challenge, clinicians must be able to tailor clinical decisions to patients’ individual circumstances by integrating biomedical with biographical accounts of illness. This skillset has not been well defined or taught. Medicines optimisation (MO) is a key clinical activity in tackling PP and can exemplify the practical wisdom required for this integration. How and why MO education works is poorly understood. Our previous work, a realist review of published interventions, addressed this gap by explaining how undergraduate MO education could work but was limited by the thin descriptions available. Here, we develop those findings by using primary data from interviews of expert educators to develop and refine our explanatory model. Methods This realist evaluation develops the programme theory from our review using primary data from individual realist interviews of MO experts. Realist configurational analysis was used. The study is conducted and reported in-keeping with RAMESES II standards. Results Sixteen experts in MO were interviewed; data were used to refine or refute our previous theorising. Analysis showed MO education which seeks to integrate interpretive practice into clinical decision-making must be valued by learners and be sufficiently aligned with educational and workplace culture to garner the engagement necessary to undertake this learning process. Learners must feel they have permission to practice interpretive medicine when healthcare structures are organised to the contrary. A perception of critical mass within a community of practice may facilitate the required security in decision-making for ongoing practice. Discussion We describe how and why undergraduate MO educational programmes can work to produce important outcomes in tackling the challenge of PP. We highlight how MO educational programmes may also act as practical gateways to routine interpretive practice in broader clinical areas.